Search research articles
Contact Us
Filters
Showing results (31-40 of 81) with videos related to
Page
of 9
Sort By:
Journal of Cancer Policy
|
December 21, 2025
INNOVATIVE ONCOLOGY TRIAL DESIGNS: TIME TO ACT A review with recommendations of the Cancer Drug Development Forum
Rosa Giuliani, Nafsika Kronidou-Horst, Christina Yap, et al.
Statistics in Medicine
|
March 16, 2026
Clinical Trial Simulation: Planning With the OCTAVE Framework, Implementation and Validation Principles
Kim May Lee, Babak Choodari-Oskooei, Michael J Grayling, et al.
British Journal of Cancer
|
July 1, 2017
Embracing model-based designs for dose-finding trials
Sharon B Love, Sarah Brown, Christopher J Weir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 18, 2019
Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia
Charles Craddock, Daniel Slade, Carmela De Santo, et al.
BMJ Open
|
September 7, 2021
Study protocol for a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials (CONSENT)
Abhijit Pal, Sarah Stapleton, Christina Yap, et al.
BMC Medical Research Methodology
|
January 20, 2019
How to design a dose-finding study using the continual reassessment method
Graham M Wheeler, Adrian P Mander, Alun Bedding, et al.
BMJ Open
|
March 19, 2020
Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the <b>WISTERIA</b> trial protocol
Anthony Kong, James Good, Amanda Kirkham, et al.
BMJ Open
|
March 29, 2023
SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol
Aude Espinasse, Olga Solovyeva, Munyaradzi Dimairo, et al.
The Lancet. Haematology
|
December 15, 2021
Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trial
Mhairi Copland, Daniel Slade, Graham McIlroy, et al.
Nature Communications
|
March 20, 2021
A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies
Adrian Creanga, Rebecca A Gillespie, Brian E Fisher, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 81) with videos related to
Sort By:
Page
of 9
Journal of Cancer Policy
|
December 21, 2025
INNOVATIVE ONCOLOGY TRIAL DESIGNS: TIME TO ACT A review with recommendations of the Cancer Drug Development Forum
Rosa Giuliani, Nafsika Kronidou-Horst, Christina Yap, et al.
Statistics in Medicine
|
March 16, 2026
Clinical Trial Simulation: Planning With the OCTAVE Framework, Implementation and Validation Principles
Kim May Lee, Babak Choodari-Oskooei, Michael J Grayling, et al.
British Journal of Cancer
|
July 1, 2017
Embracing model-based designs for dose-finding trials
Sharon B Love, Sarah Brown, Christopher J Weir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 18, 2019
Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia
Charles Craddock, Daniel Slade, Carmela De Santo, et al.
BMJ Open
|
September 7, 2021
Study protocol for a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials (CONSENT)
Abhijit Pal, Sarah Stapleton, Christina Yap, et al.
BMC Medical Research Methodology
|
January 20, 2019
How to design a dose-finding study using the continual reassessment method
Graham M Wheeler, Adrian P Mander, Alun Bedding, et al.
BMJ Open
|
March 19, 2020
Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the <b>WISTERIA</b> trial protocol
Anthony Kong, James Good, Amanda Kirkham, et al.
BMJ Open
|
March 29, 2023
SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol
Aude Espinasse, Olga Solovyeva, Munyaradzi Dimairo, et al.
The Lancet. Haematology
|
December 15, 2021
Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trial
Mhairi Copland, Daniel Slade, Graham McIlroy, et al.
Nature Communications
|
March 20, 2021
A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies
Adrian Creanga, Rebecca A Gillespie, Brian E Fisher, et al.
Page
of 9